Successful therapy with argatroban for superior mesenteric vein thrombosis in a patient with congenital antithrombin deficiency

Tsuyoshi Muta; Takashi Okamura; Masahiko Kawamoto; Hitoshi Ichimiya; Motoko Yamanaka; Yui Wada; Michiyo Urata; Yuzo Kayamori; Naotaka Hamasaki; Koji Kato; Testuya Eto; Hisashi Gondo; Tsunefumi Shibuya

doi:10.1111/j.1600-0609.2005.00480.x

Successful therapy with argatroban for superior mesenteric vein thrombosis in a patient with congenital antithrombin deficiency

Tsuyoshi Muta, Takashi Okamura, Masahiko Kawamoto, Hitoshi Ichimiya, Motoko Yamanaka, Yui Wada, Michiyo Urata, Yuzo Kayamori, Naotaka Hamasaki, Koji Kato, Testuya Eto, Hisashi Gondo, Tsunefumi Shibuya

Division of Medical Technology

Research output: Contribution to journal › Article › peer-review

9 Citations (Scopus)

Abstract

A 38-year-old woman was admitted with superior mesenteric vein (SMV) thrombosis, which was refractory to anticoagulation therapy. The plasma antithrombin activity was decreased and hardly compensated by concentrated antithrombin preparation due to high consumption rate. However, successful anticoagulation was achieved by administration of direct thrombin inhibitor, argatroban. Family studies of antithrombin activity revealed that she had type I congenital antithrombin deficiency. A novel heterozygous mutation in the gene for antithrombin (single nucleotide T insertion at 7916 and 7917, Glu 272 to stop in exon 4) was identified. Argatroban administration would be effective in the treatment of congenital antithrombin deficiency with SMV thrombosis.

Original language	English
Pages (from-to)	167-170
Number of pages	4
Journal	European Journal of Haematology
Volume	75
Issue number	2
DOIs	https://doi.org/10.1111/j.1600-0609.2005.00480.x
Publication status	Published - Aug 2005

All Science Journal Classification (ASJC) codes

Hematology

Access to Document

10.1111/j.1600-0609.2005.00480.x

Cite this

Muta, T., Okamura, T., Kawamoto, M., Ichimiya, H., Yamanaka, M., Wada, Y., Urata, M., Kayamori, Y., Hamasaki, N., Kato, K., Eto, T., Gondo, H., & Shibuya, T. (2005). Successful therapy with argatroban for superior mesenteric vein thrombosis in a patient with congenital antithrombin deficiency. European Journal of Haematology, 75(2), 167-170. https://doi.org/10.1111/j.1600-0609.2005.00480.x

Successful therapy with argatroban for superior mesenteric vein thrombosis in a patient with congenital antithrombin deficiency. / Muta, Tsuyoshi; Okamura, Takashi; Kawamoto, Masahiko; Ichimiya, Hitoshi; Yamanaka, Motoko; Wada, Yui; Urata, Michiyo; Kayamori, Yuzo; Hamasaki, Naotaka; Kato, Koji; Eto, Testuya; Gondo, Hisashi; Shibuya, Tsunefumi.

In: European Journal of Haematology, Vol. 75, No. 2, 08.2005, p. 167-170.

Research output: Contribution to journal › Article › peer-review

Muta, T, Okamura, T, Kawamoto, M, Ichimiya, H, Yamanaka, M, Wada, Y, Urata, M, Kayamori, Y, Hamasaki, N, Kato, K, Eto, T, Gondo, H & Shibuya, T 2005, 'Successful therapy with argatroban for superior mesenteric vein thrombosis in a patient with congenital antithrombin deficiency', European Journal of Haematology, vol. 75, no. 2, pp. 167-170. https://doi.org/10.1111/j.1600-0609.2005.00480.x

Muta, Tsuyoshi ; Okamura, Takashi ; Kawamoto, Masahiko ; Ichimiya, Hitoshi ; Yamanaka, Motoko ; Wada, Yui ; Urata, Michiyo ; Kayamori, Yuzo ; Hamasaki, Naotaka ; Kato, Koji ; Eto, Testuya ; Gondo, Hisashi ; Shibuya, Tsunefumi. / Successful therapy with argatroban for superior mesenteric vein thrombosis in a patient with congenital antithrombin deficiency. In: European Journal of Haematology. 2005 ; Vol. 75, No. 2. pp. 167-170.

@article{f2473e9dd841427d951be4ca456f91dd,

title = "Successful therapy with argatroban for superior mesenteric vein thrombosis in a patient with congenital antithrombin deficiency",

abstract = "A 38-year-old woman was admitted with superior mesenteric vein (SMV) thrombosis, which was refractory to anticoagulation therapy. The plasma antithrombin activity was decreased and hardly compensated by concentrated antithrombin preparation due to high consumption rate. However, successful anticoagulation was achieved by administration of direct thrombin inhibitor, argatroban. Family studies of antithrombin activity revealed that she had type I congenital antithrombin deficiency. A novel heterozygous mutation in the gene for antithrombin (single nucleotide T insertion at 7916 and 7917, Glu 272 to stop in exon 4) was identified. Argatroban administration would be effective in the treatment of congenital antithrombin deficiency with SMV thrombosis.",

author = "Tsuyoshi Muta and Takashi Okamura and Masahiko Kawamoto and Hitoshi Ichimiya and Motoko Yamanaka and Yui Wada and Michiyo Urata and Yuzo Kayamori and Naotaka Hamasaki and Koji Kato and Testuya Eto and Hisashi Gondo and Tsunefumi Shibuya",

year = "2005",

month = aug,

doi = "10.1111/j.1600-0609.2005.00480.x",

language = "English",

volume = "75",

pages = "167--170",

journal = "European Journal of Haematology",

issn = "0902-4441",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - Successful therapy with argatroban for superior mesenteric vein thrombosis in a patient with congenital antithrombin deficiency

AU - Muta, Tsuyoshi

AU - Okamura, Takashi

AU - Kawamoto, Masahiko

AU - Ichimiya, Hitoshi

AU - Yamanaka, Motoko

AU - Wada, Yui

AU - Urata, Michiyo

AU - Kayamori, Yuzo

AU - Hamasaki, Naotaka

AU - Kato, Koji

AU - Eto, Testuya

AU - Gondo, Hisashi

AU - Shibuya, Tsunefumi

PY - 2005/8

Y1 - 2005/8

N2 - A 38-year-old woman was admitted with superior mesenteric vein (SMV) thrombosis, which was refractory to anticoagulation therapy. The plasma antithrombin activity was decreased and hardly compensated by concentrated antithrombin preparation due to high consumption rate. However, successful anticoagulation was achieved by administration of direct thrombin inhibitor, argatroban. Family studies of antithrombin activity revealed that she had type I congenital antithrombin deficiency. A novel heterozygous mutation in the gene for antithrombin (single nucleotide T insertion at 7916 and 7917, Glu 272 to stop in exon 4) was identified. Argatroban administration would be effective in the treatment of congenital antithrombin deficiency with SMV thrombosis.

AB - A 38-year-old woman was admitted with superior mesenteric vein (SMV) thrombosis, which was refractory to anticoagulation therapy. The plasma antithrombin activity was decreased and hardly compensated by concentrated antithrombin preparation due to high consumption rate. However, successful anticoagulation was achieved by administration of direct thrombin inhibitor, argatroban. Family studies of antithrombin activity revealed that she had type I congenital antithrombin deficiency. A novel heterozygous mutation in the gene for antithrombin (single nucleotide T insertion at 7916 and 7917, Glu 272 to stop in exon 4) was identified. Argatroban administration would be effective in the treatment of congenital antithrombin deficiency with SMV thrombosis.

UR - http://www.scopus.com/inward/record.url?scp=22444451220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22444451220&partnerID=8YFLogxK

U2 - 10.1111/j.1600-0609.2005.00480.x

DO - 10.1111/j.1600-0609.2005.00480.x

M3 - Article

C2 - 16000134

AN - SCOPUS:22444451220

VL - 75

SP - 167

EP - 170

JO - European Journal of Haematology

JF - European Journal of Haematology

SN - 0902-4441

IS - 2

ER -

Successful therapy with argatroban for superior mesenteric vein thrombosis in a patient with congenital antithrombin deficiency

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this